Zoledronic Acid Injection, Solution, Concentrate
Product Images NDC 83634-801

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Zoledronic Acid (NDC 83634-801). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avenacy Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Zol13 0000 01)

Chemical structure diagram of zoledronic acid, showing its characteristic imidazole ring and bisphosphonate groups, consistent with the active ingredient zoledronic acid in the product Zoledronic Acid injection solution concentrate.*

FDA Label Image

Figure (Zol13 0000 02)

A bar chart depicting the proportion of complete responders by day 10 in pooled HCM studies comparing Zoledronic acid injection 4 mg and Pamidronate 90 mg (n=99). Zoledronic acid shows a higher percentage of responders, with a significant P-value of 0.002.*

FDA Label Image

Package Label – Principal Display Panel – Vial Label (Zol13 0000 03)

Label for Zoledronic Acid Injection 4 mg per 5 mL (0.8 mg/mL) sterile single-dose vial by Avenacy Inc. The label states it is for intravenous infusion after dilution, not for direct injection, and the dose must be diluted. It also includes storage instructions and the NDC 83634-801-05.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.